State Street® SPDR® S&P® Biotech ETF (XBI)

Currency in USD
121.83
+3.37(+2.84%)
Closed·
121.34-0.49(-0.40%)
·
Day's Range
118.74121.96
52 wk Range
66.66123.47

Key Statistics

Morning Star Rating
Risk Rating
Bid / Ask
-
Prev. Close
121.83
Price Open
118.76
Volume
10,791,984
Average Vol. (3m)
10,728,793
1-Year Change
25.17%
Day’s Range
118.74-121.96
52-Week Range
66.66-123.47
Market Cap
7.57B
Expense Ratio
0.35%
How do you feel today about XBI?
Vote to see community's results!
or
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10001,3671,3711,2371,4749291,728
Fund Return+36.72%+37.08%+23.73%+13.79%-1.47%+5.62%
Rank in Category97131311888
Percentile Rank7414108683
EXAS2.79%101.25+0.05%2,296,897
RVMD2.62%77.69+3.16%2,810,472
RNA2.33%71.58+0.06%2,711,156
INSM2.15%206.78+0.09%862,085
NTRA2.12%238.21+0.66%740,930
REGN2.12%723.67-2.47%226,369
MDGL2.09%579.89+1.18%292,441
BBIO2.05%74.15+3.76%2,375,407
IONS1.95%81.84+0.65%1,965,645
BIIB1.93%180.75+0.32%882,077

State Street® SPDR® S&P® Biotech ETF Company Profile

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

Industry
-
Sector
-
Equity Type
ETF

FAQ

How is the performance of XBI?

As of 04 Dec 2025, XBI is trading at a price of 121.83, with a previous close of 121.83. The stock has fluctuated within a day range of 118.74 to 121.96, while its 52-week range spans from 66.66 to 123.47.

What is the current price of XBI?

The XBI stock price today is 121.83.

Does XBI Pay Dividends? What’s The Current Dividend Yield?

The SPDR S&P Biotech dividend yield is 0.09%.

What is the ticker symbol for SPDR S&P Biotech?

The ticker symbol for SPDR S&P Biotech is XBI.

What is the XBI premarket price?

XBI's last pre-market stock price is 121.34.

What is the XBI after hours price?

XBI's last after hours stock price is 121.81.

What is the P/E ratio of XBI?

The P/E ratio for XBI is 18.91.

What is XBI?

XBI is an ETF issued by SPDR State Street Investment Management and is listed and traded on the New York Stock Exchange

From a Technical Analysis Perspective, Is XBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What is the XBI market cap?

The market cap for XBI is 8.21B.

When is the XBI dividend date?

The next dividend date for XBI is 21 Sept 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.